Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
about
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterationsImmunotherapy of Trypanosoma cruzi infection with DNA vaccines in miceDifferential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineageChagas diseaseEpidemiological modeling of Trypanosoma cruzi: Low stercorarian transmission and failure of host adaptive immunity explain the frequency of mixed infections in humansOn the definition of a criterion of immunogenicity.Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection.Structural and immunological characterization of sulphatides: relevance of sulphate moieties in Trypanosoma cruzi glycoconjugates.Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infectionAnalysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infectionNonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi InfectionGeneration, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.Innate and acquired immunity in the pathogenesis of Chagas disease.DNA vaccines against tropical parasitic diseases.Current status and future prospects for a vaccine against American trypanosomiasis.Chagas cardiomyopathy and ischemic stroke.Evolution and pathology in chagas disease--a review.Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy.Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathyBack to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.Current status of Chagas disease chemotherapy.Acute myocarditis in children.The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.Analysis of association of FOXO3 gene with Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy.Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.Modulation of autoimmunity by treatment of an infectious disease.Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice.Comprehensive analysis of three TYK2 gene variants in the susceptibility to Chagas disease infection and cardiomyopathy.Effects of repetitive stress during the acute phase of Trypanosoma cruzi infection on chronic Chagas' disease in rats.Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity.Distribution of HLA-DRB1 alleles in Argentinean patients with Chagas' disease cardiomyopathy.Outcomes of Trypanosoma cruzi and Trypanosoma evansi infections on health of Southern coati (Nasua nasua), crab-eating fox (Cerdocyon thous), and ocelot (Leopardus pardalis) in the Brazilian PantanalDecreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG
P2860
Q24520510-78693EA2-69B2-4245-8D12-979589A576E8Q24602785-CC84A109-5669-4769-87F5-8B822A365ABBQ28481727-4B026C8A-6F38-46B9-81ED-3E58DCA31905Q28755203-C82F5C9C-F0BD-4AC9-A78B-3A77DACA89B8Q33714036-55935A37-A91E-4332-ABDB-20CA5E18F71AQ34000887-0248EFAC-B854-4791-BFF4-0F3FF3D5B2CFQ34310471-CA78DF1B-8576-4BE6-81C1-60CBFFC14EFBQ34318631-E56147F8-EF77-406B-A42F-9346117B7653Q34549735-B4C2C15C-AAFF-4645-8C15-A5F5B79AEFEDQ34775976-0C99B55A-C7BE-4300-90C0-E6834DEC601CQ35173250-5DF6BA8F-207E-4B05-9EE2-15B839C23968Q35884259-EF1870CA-FBE4-48D7-9BD7-EB5108027962Q35994773-70F9F2B7-08B9-4D84-B3BC-81DA70673F2AQ36238733-9F59F504-D923-439B-86A7-91F6BA3F8277Q36350576-3CD58EFC-DFED-4546-B5BA-D799CCA32EE6Q36352043-7EAA6F06-1999-4456-9E5E-F32D5A4C05E2Q36637937-3156CC7D-FD0F-43FA-99B6-24CE1E611FF3Q37159862-E9CB8267-57C1-4AE9-A601-DE9B8120B812Q37272449-F1B449D7-74E5-4DC1-AF39-7B2BFD90051EQ37597057-06572CD9-8D7F-4A8B-82A7-A33207F7F476Q37879205-C2259311-F720-4258-81D4-DA04A9EFEEC6Q37895688-BADA415C-9852-491D-AE7A-05D5291A783CQ37961913-BA757066-B2A0-475F-9285-5A486E4C078EQ39813174-7E226518-8BA9-4C02-A965-D55193ECBA19Q41387443-AF2AE11F-F8E4-40E3-8D75-33BF47237B24Q42432412-0E739E71-4FF5-476A-B68A-E6CFF3D59F6AQ43211997-7D76954A-37CA-4535-A806-9080A4E00CA0Q48302749-E00E8C2B-B5EA-4557-9863-1870BDB68083Q48469693-577D9371-5403-4E60-BA0C-CFDF98629521Q51798355-533F8F86-45EA-4B94-9FB3-E4A16EF971C7Q54234613-63B401D6-1C7D-42DD-825F-F1508326468EQ54460390-BAA3A01E-7922-448C-91C0-DD685F972D73Q58778869-EC2A4AE3-1F2E-4EBF-85F9-54C9AE0A331AQ58855037-75FEB6A5-E50C-487E-8E7F-06CB88BCF54A
P2860
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@en
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@nl
type
label
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@en
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@nl
prefLabel
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@en
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@nl
P1476
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?
@en
P356
10.1016/S1471-4922(02)00006-5
P577
2003-01-01T00:00:00Z